ImmunityBio, Inc. IBRX

Moderna is a joke loses 3.1 billion a year the melanoma jab is individually made for each person. Insanely expensive....

Did we forget mRNA jabs cause blood clots strokes autoimmune issues myocarditis leading to cardiomyopathy plus plus plus other adverse side effects.
The mRNA jab for cancer will never take off other treatments including Anktiva will dominate.

👉👿🖕Daredevil the ☠️🤡💩🖕

Moderna personalized mRNA for melanoma will cost a fortune. It's made for each patient. Remember it's still mRNA which causes blood clots, strokes, sudden death, myocarditis leading to cardiomyopathy plus plus plus.....

It will be rarely used if at all and other better treatments will be used.

Today's topic they are talking fear again. Who decides and releases this stuff? The government.....

"Ai & bioweapons and super charged biology"

I am correct, Covid was CIA Department of Defense planned to fast approve mRNA jabs.

mRNA to the rescue to save us from Ai bioweapons and super charged biology.

It's all so predictable unless you are blind, deaf and hello yes add in stupid.

Kerry hello dumbass Merck don't make a jab.

Moderna Pfizer and J&J made the jabs.

Just because Moderna MRNA is treating cancer the treatment mRNA can't be poison and cause injuries and death.

Wake up you idiots. New FDA in town and BP is in trouble and Moderna is losing 3.1 billion a year. So Don't buy don't buy.

ImmunityBio would work with Keytruda

Moderna MRNA what a joke market cap 70 billion and losing $7.98 a share so 7.98x400,000,000=3,192,000,000 losing 3.1 billion a year and the stock rockets up on phase 3 positive results I would short MRNA not buy it.

So sick of the rigged corrupt America

So MRNA Moderna 🚀 nearly triples on a positive late stage clinical trial results for Melanoma. Not approved, not submitted for approval, just positive results in a phase 3
Clinical trial.

So it nearly triples because of MSM coverage, it's all over the news and 🚀 boom.

ImmunityBio and Anktiva have an approval, another is on the way and positive results in several clinical trials but it doesn't double, triple or quadruple. Why??? The $$$$ corrupted MSM coverage happens for Merck but doesn't happen for IBRX because it doesnt spend billions on advertising.